POTASSIUM MONITORING IN HEART FAILURE PATIENTS RECEIVING COMBINED THERAPY OF CAPTOPRIL AND FUROSEMIDE
In the treatment of heart failure is recommended the use of a combination of ACEI (captopril) with diuretics (furosemide), ACEI has the side effect of hyperkalemia 10-38% in hospitalized patients and 10% in outpatients, is increased in patients with renal failure and diabetes mellitus, the use diure...
Main Authors: | Hubby Hubby, Suharjono Suharjono, Zaenab Djafar |
---|---|
Format: | Article |
Language: | English |
Published: |
Universitas Airlangga
2017-08-01
|
Series: | Folia Medica Indonesiana |
Subjects: | |
Online Access: | https://e-journal.unair.ac.id/FMI/article/view/5477 |
Similar Items
-
Furosemide and spironolactone doses and hyponatremia in patients with heart failure
by: Ivan Velat, et al.
Published: (2020-08-01) -
Safety and Efficacy of Adding Dapagliflozin to Furosemide in Type 2 Diabetic Patients With Decompensated Heart Failure and Reduced Ejection Fraction
by: Ayman Ibrahim, et al.
Published: (2020-12-01) -
In dogs with congestive heart failure, is torasemide superior to furosemide as a first line diuretic treatment?
by: Leo Packham
Published: (2020-11-01) -
Influence of abnormal potassium levels on mortality among hospitalized heart failure patients in the US: data from National Inpatient Sample
by: Sijan Basnet, et al.
Published: (2019-03-01) -
Oral Treatment of Spontaneously Hypertensive Rats with Captopril-Surface Functionalized Furosemide-Loaded Multi-Wall Lipid-Core Nanocapsules
by: Cecilia B. Michalowski, et al.
Published: (2020-01-01)